Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.


Biotechnology

Pharmaceutical

Aktis Oncology

Aktis Oncology's headquarters in Boston, MA, United States

Matthew Roden

Paul L. Feldman

Shulamit Ron-Bigger

Mary Burt

Akos Czibere M.D.

Karen Mccarthy

Carlos Rodriguez

Pankaj Bhargava

Germo Gericke

Markus Reschke

Johannes Czernin

Ken Herrmann

Erik Chelius

Todd Foley

Jason Ruth

Dane Wittrup

Gary Glick

Helen Kim

Kevin Raidy

Oleg Nodelman

Lloyd M. Segal

Patrick Baeuerle

The Scientific Research Team at Aktis Oncology focuses on the discovery and development of innovative targeted radiopharmaceuticals to treat various solid tumor cancers. This multidisciplinary team conducts cutting-edge research encompassing chemistry, manufacturing, pharmacokinetics, and biology to advance the company's therapeutic pipeline.

Scientific Research Team

The Leadership Team at Aktis Oncology is responsible for setting the strategic direction and vision of the company as it pioneers innovative targeted radiopharmaceuticals. This diverse team combines expertise across business development, finance, research, and operational functions to drive the successful discovery, development, and commercialization of therapies aimed at treating solid tumor cancers. They collaborate closely to foster a culture of innovation and ensure alignment with regulatory and market demands.

Leadership Team

This department conducts advanced research and experimentation to develop and innovate within the scientific field.

Scientific Research

The Advisory Team at Aktis Oncology provides strategic guidance and expert insights to support the company's efforts in pioneering targeted radiopharmaceuticals for solid tumor cancers. Leveraging their extensive experience in biotechnology and oncology, they advise on scientific research, clinical development, and regulatory strategies to drive innovation and ensure successful outcomes.

Advisory Team

This department oversees the planning, execution, and management of clinical trials and related activities to ensure the successful development of new therapies.

Clinical Operations

This department focuses on the research, manufacture, and quality control of radiopharmaceuticals.

Aktis Oncology

Org chart

Board & advisors

Teams

Scientific Research Team

Leadership Team

Scientific Research

Advisory Team

Clinical Operations

Radiopharmaceutical Development

Offices

Aktis Oncology

Org chart

Board & advisors

Teams

Scientific Research Team

Leadership Team

Scientific Research

Advisory Team

Clinical Operations

Radiopharmaceutical Development

Offices

Related companies